HANSOH PHARMAC. HD-00001 (3KY) — Defensive Interval Ratio

Latest as of December 2025: 254 days

HANSOH PHARMAC. HD-00001 (3KY) has a Defensive Interval Ratio of 254 days as of December 2025. Defensive assets of €3.06 Billion (cash €-, short-term investments €17.61 Million, receivables €3.04 Billion) cover 254 days of daily cash needs of €12.04 Million/day. For the complete balance sheet picture, see HANSOH PHARMAC. HD-00001 balance sheet assets.

Defensive Interval Ratio

254 days
Days of operational coverage

Defensive Assets

€3.06 Billion
Cash + ST Investments + Receivables

Daily Cash Need

€12.04 Million
Current Liabilities ÷ 365

Current Liabilities

€4.39 Billion
EUR

HANSOH PHARMAC. HD-00001 Defensive Interval Ratio (2021–2025)

This chart shows how HANSOH PHARMAC. HD-00001's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 254 days, meaning defensive assets of €3.06 Billion can fund 254 days of operations without new revenue. Check HANSOH PHARMAC. HD-00001 liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Annual Defensive Interval Ratio for HANSOH PHARMAC. HD-00001 (2021–2025)

The table below presents the year-by-year Defensive Interval Ratio for HANSOH PHARMAC. HD-00001 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 254 days €3.06 Billion €12.04 Million/day €- €17.61 Million ▼ -273 days
2024 527 days €3.89 Billion €7.38 Million/day €- €764.71 Million ▲ +228 days
2023 300 days €5.63 Billion €18.80 Million/day €- €2.42 Billion ▼ -751 days
2022 1051 days €7.54 Billion €7.18 Million/day €- €4.01 Billion ▲ +148 days
2021 903 days €7.48 Billion €8.28 Million/day €- €4.23 Billion
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)